Srdan Verstovsek, MD
M.D. Anderson Cancer Center
7
7
6
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
John Mascarenhas, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Guillermo Garcia-Manero, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Vincenzo Liso, MD
UO Universita degi Studi Policinico Ematologia
Shared therapeutic areas:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
Wendy Stock, MD
University of Chicago Hospital
Shared therapeutic areas:
Vernon Louw, MD
Free State University
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Gary Schiller, MD
University of California, Los Angeles
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
Pomalidomide for Myelofibrosis Patients
Lenalidomide for Patients With Myelofibrosis (MF)
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)
All 7 trials loaded